Active or prior cancer BPC-157 promotes angiogenesis in animal models
Glutamine, through conversion to glutamate and subsequently to -ketoglutarate (-KG), not only fuels the tricarboxylic acid (TCA) cycle for energy generation but also contributes carbon skeletons for lipid, carbohydrate, and nucleotide biosynthesis, thus sustaining the high metabolic demands of activated fibroblasts [8]
Manages oxidative stress by protecting skin cells from free radicals
Side Effects, Risks and Considerations While these medications are effective, there are some additional factors to consider prior to commencing treatment
Observational data from practitioner-supervised use, even informal, contribute to the pre-clinical-to-clinical evidence bridge that BPC-157 currently lacks
Several trials are exploring next-generation mutant-selective agents